ATP11B Modulates Microglial Lipid Metabolism and Alleviates Alzheimer's Disease Pathology

Abstract

Abnormal lipid metabolism in microglia leads to the formation of pathological lipid droplets (LDs), a phenomenon also observed in neurodegenerative diseases such as Alzheimer's disease (AD). The abnormal accumulation of LDs disrupts normal cellular function and exacerbates the pathological process of AD. ATP11B is a P4-ATPase and the expression of Atp11b changes in the brain of patients with AD and diseases of lipid metabolism. The present study aimed to explore the regulatory role of ATP11B in microglial lipid metabolism and assess the potential of ATP11B as a therapeutic target for AD. Atp11b deficiency caused excessive fatty acid uptake and activated the PPAR signaling pathway, resulting in abnormal synthesis of neutral lipids and mitochondrial energy metabolism in microglia. Further results showed that Atp11b deficiency led to the accumulation of pathological LDs in microglia and AD mice. Conversely, overexpression of Atp11b alleviated exploratory behavior impairment, learning and memory impairment, LD accumulation, beta-amyloid (Aβ) deposition, and inflammatory response in the brain of AD mice. These findings provide important clues for a better understanding of the pathogenesis of AD and for developing novel therapeutic strategies.

Keywords

Alzheimer's disease / ATP11B / lipid droplets / lipid metabolism / microglia

References

[1] C. L. Jackson, “Lipid Droplet Biogenesis,” Current Opinion in Cell Biology 59 (2019): 88-96.

[2] J. A. Olzmann and P. Carvalho, “Dynamics and Functions of Lipid Droplets,” Nature Reviews Molecular Cell Biology 20, no. 3 (2019): 137-155.

[3] M. J. Moulton, S. Barish, I. Ralhan, et al., “Neuronal ROS-induced Glial Lipid Droplet Formation Is Altered by Loss of Alzheimer's Disease-associated Genes,” PNAS 118, no. 52 (2021): e2112095118.

[4] I. Ralhan, C. L. Chang, J. Lippincott-Schwartz, and M. S. Ioannou, “Lipid Droplets in the Nervous System,” Journal of Cell Biology 220, no. 7 (2021): e202102136.

[5] Q. Li, Y. Zhao, H. Guo, et al., “Impaired Lipophagy Induced-microglial Lipid Droplets Accumulation Contributes to the Buildup of TREM1 in Diabetes-associated Cognitive Impairment,” Autophagy 19, no. 10 (2023): 2639-2656.

[6] X. Guo, Q. Shi, W. Zhang, et al., “Lipid Droplet-a New Target in Ischemic Heart Disease,” Journal of Cardiovascular Translational Research 15, no. 4 (2022): 730-739.

[7] L. Liu, K. Zhang, H. Sandoval, et al., “Glial Lipid Droplets and ROS Induced by Mitochondrial Defects Promote Neurodegeneration,” Cell 160, no. 1-2 (2015): 177-190.

[8] A. Mitrofanova, S. Merscher, and A. Fornoni, “Kidney Lipid Dysmetabolism and Lipid Droplet Accumulation in Chronic Kidney Disease,” Nature Reviews Nephrology 19, no. 10 (2023): 629-645.

[9] A. Zadoorian, X. Du, and H. Yang, “Lipid Droplet Biogenesis and Functions in Health and Disease,” Nature Reviews Endocrinology 19, no. 8 (2023): 443-459.

[10] J. Marschallinger, T. Iram, M. Zardeneta, et al., “Lipid-droplet-accumulating Microglia Represent a Dysfunctional and Proinflammatory state in the Aging Brain,” Nature Neuroscience 23, no. 2 (2020): 194-208.

[11] M. S. Haney, R. Pálovics, C. N. Munson, et al., “APOE4/4 is Linked to Damaging Lipid Droplets in Alzheimer's Disease Microglia,” Nature 628, no. 8006 (2024): 154-161.

[12] C. Claes, E. P. Danhash, J. Hasselmann, et al., “Plaque-associated human Microglia Accumulate Lipid Droplets in a Chimeric Model of Alzheimer's Disease,” Molecular Neurodegeneration 16, no. 1 (2021b): 50.

[13] F. Bernier, T. Kuhara, and J. Xiao, “Probiotic Bifidobacterium Breve MCC1274 Protects Against Oxidative Stress and Neuronal Lipid Droplet Formation via PLIN4 Gene Regulation,” Microorganisms 11, no. 3 (2023): 791.

[14] A. Alzheimer, “Uber Eine Eigenartige Erkrankung der Hirnrinde,” Allgemeine Zeitschrift Für Psychiatrie Und psychisch-Gerichtliche Medizin 64 (1907): 146-148.

[15] H. Huang, J. R. Bach, H. S. Sharma, et al., “The 2023 Yearbook of Neurorestoratology,” Journal of Neurorestoratology 12, no. 3 (2024): 100136, https://www.sciencedirect.com/science/article/pii/S2324242624000433.

[16] H. Huang, J. R. Bach, H. S. Sharma, et al., “The 2022 Yearbook of Neurorestoratology,” Journal of Neurorestoratology 11, no. 2 (2023): 100054.

[17] L. K. Hamilton, M. Dufresne, S. E. Joppé, et al., “Aberrant Lipid Metabolism in the Forebrain Niche Suppresses Adult Neural Stem Cell Proliferation in an Animal Model of Alzheimer's Disease,” Cell Stem Cell 17, no. 4 (2015): 397-411.

[18] V. Teixeira, P. Maciel, and V. Costa, “Leading the Way in the Nervous System: Lipid Droplets as New Players in Health and Disease,” Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1866, no. 1 (2021): 158820.

[19] M. Gedam, M. M. Comerota, N. E. Propson, et al., “Complement C3aR Depletion Reverses HIF-1α-induced Metabolic Impairment and Enhances Microglial Response to Aβ Pathology,” Journal of Clinical Investigation 133, no. 12 (2023): e167501.

[20] L. D. Goodman, I. Ralhan, X. Li, et al., “Tau Is Required for Glial Lipid Droplet Formation and Resistance to Neuronal Oxidative Stress,” Nature Neuroscience 27, no. 10 (2024): 1918-1933.

[21] M. Perluigi, F. Di Domenico, and D. A. Butterfield, “Oxidative Damage in Neurodegeneration: Roles in the Pathogenesis and Progression of Alzheimer Disease,” Physiological Reviews 104, no. 1 (2024): 103-197.

[22] R. van der Kant, V. F. Langness, C. M. Herrera, et al., “Cholesterol Metabolism Is a Druggable Axis That Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer's Disease Neurons,” Cell Stem Cell 24, no. 3 (2019): 363-375.e9.

[23] B. C. Farmer, J. Kluemper, and L. A. Johnson, “Apolipoprotein E4 Alters Astrocyte Fatty Acid Metabolism and Lipid Droplet Formation,” Cells 8, no. 2 (2019): 182.

[24] J. Lee, T. Homma, T. Kurahashi, E. S. Kang, and J. Fujii, “Oxidative Stress Triggers Lipid Droplet Accumulation in Primary Cultured Hepatocytes by Activating Fatty Acid Synthesis,” Biochemical and Biophysical Research Communications 464, no. 1 (2015): 229-235.

[25] L. Liu, K. R. MacKenzie, N. Putluri, M. Maletić-Savatić, and H. J. Bellen, “The Glia-Neuron Lactate Shuttle and Elevated ROS Promote Lipid Synthesis in Neurons and Lipid Droplet Accumulation in Glia via APOE/D,” Cell Metabolism 26, no. 5 (2017): 719-737.e6.

[26] M. B. Victor, N. Leary, X. Luna, et al., “Lipid Accumulation Induced by APOE4 Impairs Microglial Surveillance of Neuronal-network Activity,” Cell Stem Cell 29, no. 8 (2022): 1197-1212.e8.

[27] P. Gaudet, M. S. Livstone, S. E. Lewis, and P. D. Thomas, “Phylogenetic-based Propagation of Functional Annotations Within the Gene Ontology Consortium,” Briefings in Bioinformatics 12, no. 5 (2011): 449-462.

[28] M. S. Halleck, J. F. Jr Lawler, S. Blackshaw, et al., “Differential Expression of Putative Transbilayer Amphipath Transporters,” Physiological Genomics 1, no. 3 (1999): 139-150.

[29] A. M. Smith, K. Davey, S. Tsartsalis, et al., “Diverse human Astrocyte and Microglial Transcriptional Responses to Alzheimer's Pathology,” Acta Neuropathologica 143, no. 1 (2022): 75-91.

[30] Z. P. Chen, S. Wang, X. Zhao, et al., “Lipid-accumulated Reactive Astrocytes Promote Disease Progression in Epilepsy,” Nature Neuroscience 26, no. 4 (2023): 542-554.

[31] C. Wang, H. Zhang, J. Fan, et al., “Inhibition of Integrated Stress Response Protects Against Lipid-induced Senescence in Hypothalamic Neural Stem Cells in Adamantinomatous Craniopharyngioma,” Neuro-Oncology 25, no. 4 (2023): 720-732.

[32] L. Chernyaeva, G. Ratti, L. Teirilä, et al., “Reduced Binding of apoE4 to Complement Factor H Promotes Amyloid-β Oligomerization and Neuroinflammation,” EMBO Reports 24, no. 7 (2023): e56467.

[33] V. A. Moser, M. J. Workman, S. J. Hurwitz, R. M. Lipman, C. J. Pike, and C. N. Svendsen, “Microglial Transcription Profiles in Mouse and human Are Driven by APOE4 and Sex,” Iscience 24, no. 11 (2021): 103238.

[34] H. Takatsu, K. Baba, T. Shima, et al., “ATP9B, a P4-ATPase (a putative aminophospholipid translocase), Localizes to the Trans-Golgi Network in a CDC50 Protein-independent Manner,” Journal of Biological Chemistry 286, no. 44 (2011): 38159-38167.

[35] R. V. Farese and T. C. Walther, “Glycerolipid Synthesis and Lipid Droplet Formation in the Endoplasmic Reticulum,” Cold Spring Harbor Perspectives in Biology 15, no. 5 (2023): a041246.

[36] J. Qu, S. Fourman, M. Fitzgerald, et al., “Low-density Lipoprotein Receptor-related Protein 1 (LRP1) Is a Novel Receptor for Apolipoprotein A4 (APOA4) in Adipose Tissue,” Scientific Reports 11, no. 1 (2021): 13289.

[37] B. A. Loving and K. D. Bruce, “Lipid and Lipoprotein Metabolism in Microglia,” Frontiers in Physiology 11 (2020): 393.

[38] P. Morigny, J. Boucher, P. Arner, and D. Langin, “Lipid and Glucose Metabolism in White Adipocytes: Pathways, Dysfunction and Therapeutics,” Nature Reviews Endocrinology 17, no. 5 (2021): 276-295.

[39] J. Wang, W. Li, F. Zhou, et al., “ATP11B deficiency Leads to Impairment of Hippocampal Synaptic Plasticity,” Journal of Molecular Cell Biology 11, no. 8 (2019): 688-702.

[40] M. T. Nakamura, B. E. Yudell, and J. J. Loor, “Regulation of Energy Metabolism by Long-chain Fatty Acids,” Progress in Lipid Research 53 (2014): 124-144.

[41] T. C. Walther and J. Chung, “Lipid Droplet Biogenesis,” Annual Review of Cell and Developmental Biology 33 (2017): 491-510.

[42] M. Edwards and S. S. Mohiuddin, “Biochemistry, Lipolysis,” Dans StatPearls (Treasure Island (FL): StatPearls Publishing LLC, 2023). Ineligible Companies. Disclosure: Shamim Mohiuddin Declares no Relevant Financial Relationships With Ineligible Companies.: StatPearls Publishing Copyright © 2023.

[43] T. Zotti, A. Giacco, A. Cuomo, et al., “Exercise Equals the Mobilization of Visceral versus Subcutaneous Adipose Fatty Acid Molecules in Fasted Rats Associated With the Modulation of the AMPK/ATGL/HSL Axis,” Nutrients 15, no. 14 (2023): 3095.

[44] T. T. T. Nguyen, Y. Zhang, E. Shang, et al., “HDAC Inhibitors Elicit Metabolic Reprogramming by Targeting Super-enhancers in Glioblastoma Models,” Journal of Clinical Investigation 130, no. 7 (2020): 3699-3716.

[45] I. Y. Benador, M. Veliova, M. Liesa, and O. S. Shirihai, “Mitochondria Bound to Lipid Droplets: Where Mitochondrial Dynamics Regulate Lipid Storage and Utilization,” Cell Metabolism 29, no. 4 (2019): 827-835.

[46] I. Y. Benador, M. Veliova, K. Mahdaviani, et al., “Mitochondria Bound to Lipid Droplets Have Unique Bioenergetics, Composition, and Dynamics That Support Lipid Droplet Expansion,” Cell Metabolism 27, no. 4 (2018): 869-885.e6.

[47] H. Chew, V. A. Solomon, and A. N. Fonteh, “Involvement of Lipids in Alzheimer's Disease Pathology and Potential Therapies,” Frontiers in Physiology 11 (2020): 598.

[48] Y. Combot, V. T. Salo, G. Chadeuf, et al., “Seipin Localizes at Endoplasmic-reticulum-mitochondria Contact Sites to Control Mitochondrial Calcium Import and Metabolism in Adipocytes,” Cell Reports 38, no. 2 (2022): 110213.

[49] L. P. Bernier, E. M. York, A. Kamyabi, H. B. Choi, N. L. Weilinger, and B. A. MacVicar, “Microglial Metabolic Flexibility Supports Immune Surveillance of the Brain Parenchyma,” Nature Communications 11, no. 1 (2020): 1559.

[50] A. P. Bailey, G. Koster, C. Guillermier, et al., “Antioxidant Role for Lipid Droplets in a Stem Cell Niche of Drosophila,” Cell 163, no. 2 (2015): 340-353.

[51] C. Claes, E. P. Danhash, J. Hasselmann, et al., “Plaque-associated human Microglia Accumulate Lipid Droplets in a Chimeric Model of Alzheimer's Disease,” Molecular Neurodegeneration 16, no. 1 (2021a): 50.

[52] G. Gouna, C. Klose, M. Bosch-Queralt, et al., “TREM2-dependent Lipid Droplet Biogenesis in Phagocytes Is Required for Remyelination,” Journal of Experimental Medicine 218, no. 10 (2021): e20210227.

[53] C. C. Liu, N. Wang, Y. Chen, et al., “Cell-autonomous Effects of APOE4 in Restricting Microglial Response in Brain Homeostasis and Alzheimer's Disease,” Nature Immunology 24, no. 11 (2023): 1854-1866.

[54] Y. Shi and D. M. Holtzman, “Interplay Between Innate Immunity and Alzheimer Disease: APOE and TREM2 in the Spotlight,” Nature Reviews Immunology 18, no. 12 (2018): 759-772.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.